Status:
COMPLETED
Self-Advocacy Serious Game in Advanced Cancer
Lead Sponsor:
University of Pittsburgh
Conditions:
Ovarian Cancer Stage III
Ovarian Cancer Stage IV
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Self-advocacy, defined as the ability of a patient to get her needs and priorities met in the face of a challenge, is an essential skill but not all women with advanced cancer are able to do it. We wa...
Detailed Description
Background: When faced with the challenges of advanced cancer, women must advocate (or stand up) for their needs and priorities. However, there are no interventions to promote self-advocacy among fema...
Eligibility Criteria
Inclusion
- Female
- ≥18 years
- Diagnosed with Stage III or IV gynecological or Stage IV breast cancer within the past 3 months being treated with non-curative intent
- Have at least a 6-month life expectancy (as determined by their oncologist)
- Eastern Cooperative Oncology Group performance score of 0 to 2 (per health record or oncologist)
- Able to read and write in English
Exclusion
- On hospice at the time of recruitment
- Impaired cognition (per health record)
- Other active, unstable mental health disorder
Key Trial Info
Start Date :
December 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 18 2021
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT03339765
Start Date
December 13 2018
End Date
March 18 2021
Last Update
July 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15261